Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

89 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A novel class of AMPA receptor allosteric modulators. Part 1: design, synthesis, and SAR of 3-aryl-4-cyano-5-substituted-heteroaryl-2-carboxylic acid derivatives.
Fernandez MC, Castaño A, Dominguez E, Escribano A, Jiang D, Jimenez A, Hong E, Hornback WJ, Nisenbaum ES, Rankl N, Tromiczak E, Vaught G, Zarrinmayeh H, Zimmerman DM. Fernandez MC, et al. Among authors: zimmerman dm. Bioorg Med Chem Lett. 2006 Oct 1;16(19):5057-61. doi: 10.1016/j.bmcl.2006.07.035. Epub 2006 Aug 1. Bioorg Med Chem Lett. 2006. PMID: 16879964
A novel class of positive allosteric modulators of AMPA receptors: design, synthesis, and structure-activity relationships of 3-biphenyl-4-yl-4-cyano-5-ethyl-1-methyl-1H-pyrrole-2-carboxylic acid, LY2059346.
Zarrinmayeh H, Tromiczak E, Zimmerman DM, Rankl N, Ho KH, Dominguez E, Castaño A, Escribano A, Fernandez C, Jimenez A, Hornback WJ, Nisenbaum ES. Zarrinmayeh H, et al. Among authors: zimmerman dm. Bioorg Med Chem Lett. 2006 Oct 1;16(19):5203-6. doi: 10.1016/j.bmcl.2006.07.012. Epub 2006 Jul 25. Bioorg Med Chem Lett. 2006. PMID: 16872827
AMPA receptor potentiators for the treatment of CNS disorders.
O'Neill MJ, Bleakman D, Zimmerman DM, Nisenbaum ES. O'Neill MJ, et al. Among authors: zimmerman dm. Curr Drug Targets CNS Neurol Disord. 2004 Jun;3(3):181-94. doi: 10.2174/1568007043337508. Curr Drug Targets CNS Neurol Disord. 2004. PMID: 15180479 Review.
Biarylpropylsulfonamides as novel, potent potentiators of 2-amino-3- (5-methyl-3-hydroxyisoxazol-4-yl)- propanoic acid (AMPA) receptors.
Ornstein PL, Zimmerman DM, Arnold MB, Bleisch TJ, Cantrell B, Simon R, Zarrinmayeh H, Baker SR, Gates M, Tizzano JP, Bleakman D, Mandelzys A, Jarvie KR, Ho K, Deverill M, Kamboj RK. Ornstein PL, et al. Among authors: zimmerman dm. J Med Chem. 2000 Nov 16;43(23):4354-8. doi: 10.1021/jm0002836. J Med Chem. 2000. PMID: 11087558 No abstract available.
LY503430, a novel alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor potentiator with functional, neuroprotective and neurotrophic effects in rodent models of Parkinson's disease.
Murray TK, Whalley K, Robinson CS, Ward MA, Hicks CA, Lodge D, Vandergriff JL, Baumbarger P, Siuda E, Gates M, Ogden AM, Skolnick P, Zimmerman DM, Nisenbaum ES, Bleakman D, O'Neill MJ. Murray TK, et al. Among authors: zimmerman dm. J Pharmacol Exp Ther. 2003 Aug;306(2):752-62. doi: 10.1124/jpet.103.049445. Epub 2003 May 2. J Pharmacol Exp Ther. 2003. PMID: 12730350
Potent and selective 1,2,3-trisubstituted indole NPY Y-1 antagonists.
Hipskind PA, Lobb KL, Nixon JA, Britton TC, Bruns RF, Catlow J, Dieckman-McGinty DK, Gackenheimer SL, Gitter BD, Iyengar S, Schober DA, Simmons RM, Swanson S, Zarrinmayeh H, Zimmerman DM, Gehlert DR. Hipskind PA, et al. Among authors: zimmerman dm. J Med Chem. 1997 Nov 7;40(23):3712-4. doi: 10.1021/jm970512x. J Med Chem. 1997. PMID: 9371234 No abstract available.
89 results